ID   SYT1_RAT                Reviewed;         421 AA.
AC   P21707; Q3S2E6; Q707P5;
DT   01-MAY-1991, integrated into UniProtKB/Swiss-Prot.
DT   02-MAY-2006, sequence version 3.
DT   22-JUL-2015, entry version 159.
DE   RecName: Full=Synaptotagmin-1;
DE   AltName: Full=Synaptotagmin I;
DE            Short=SytI;
DE   AltName: Full=p65;
GN   Name=Syt1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2333096; DOI=10.1038/345260a0;
RA   Perin M.S., Fried V.A., Mignery G.A., Jahn R., Suedhof T.C.;
RT   "Phospholipid binding by a synaptic vesicle protein homologous to the
RT   regulatory region of protein kinase C.";
RL   Nature 345:260-263(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=15238157; DOI=10.1186/1471-2164-5-43;
RA   Craxton M.A.;
RT   "Synaptotagmin gene content of the sequenced genomes.";
RL   BMC Genomics 5:43-43(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE.
RC   STRAIN=Wistar;
RA   Sunitha S.S., Thekkuveettil A.;
RT   "Functional analysis of synaptotagmin.";
RL   Submitted (APR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   PROTEIN SEQUENCE OF 214-233; 289-297; 355-366 AND 376-388, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Hippocampus;
RA   Lubec G., Chen W.-Q.;
RL   Submitted (APR-2007) to UniProtKB.
RN   [5]
RP   INTERACTION WITH SV2A, AND DOMAIN.
RX   PubMed=8910372; DOI=10.1074/jbc.271.44.27770;
RA   Schivell A.E., Batchelor R.H., Bajjalieh S.M.;
RT   "Isoform-specific, calcium-regulated interaction of the synaptic
RT   vesicle proteins SV2 and synaptotagmin.";
RL   J. Biol. Chem. 271:27770-27775(1996).
RN   [6]
RP   INTERACTION WITH RIMS1.
RC   TISSUE=Brain;
RX   PubMed=11438518; DOI=10.1074/jbc.M100929200;
RA   Coppola T., Magnin-Luethi S., Perret-Menoud V., Gattesco S.,
RA   Schiavo G., Regazzi R.;
RT   "Direct interaction of the Rab3 effector RIM with Ca2+ channels, SNAP-
RT   25, and synaptotagmin.";
RL   J. Biol. Chem. 276:32756-32762(2001).
RN   [7]
RP   PALMITOYLATION AT CYS-74; CYS-75; CYS-77; CYS-79 AND CYS-82.
RX   PubMed=12782290; DOI=10.1016/S0014-5793(03)00449-6;
RA   Heindel U., Schmidt M.F., Veit M.;
RT   "Palmitoylation sites and processing of synaptotagmin I, the putative
RT   calcium sensor for neurosecretion.";
RL   FEBS Lett. 544:57-62(2003).
RN   [8]
RP   INTERACTION WITH SV2A; SV2B AND SV2C.
RX   PubMed=15866046; DOI=10.1016/j.mcn.2004.12.011;
RA   Schivell A.E., Mochida S., Kensel-Hammes P., Custer K.L.,
RA   Bajjalieh S.M.;
RT   "SV2A and SV2C contain a unique synaptotagmin-binding site.";
RL   Mol. Cell. Neurosci. 29:56-64(2005).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 132-266.
RX   PubMed=7697723; DOI=10.1016/0092-8674(95)90296-1;
RA   Sutton R.B., Davletov B.A., Berghuis A.M., Suedhof T.C., Sprang S.R.;
RT   "Structure of the first C2 domain of synaptotagmin I: a novel
RT   Ca2+/phospholipid-binding fold.";
RL   Cell 80:929-938(1995).
RN   [10]
RP   STRUCTURE BY NMR OF 140-267.
RX   PubMed=9819203; DOI=10.1021/bi981789h;
RA   Shao X., Fernandez I., Suedhof T.C., Rizo J.;
RT   "Solution structures of the Ca2+-free and Ca2+-bound C2A domain of
RT   synaptotagmin I: does Ca2+ induce a conformational change?";
RL   Biochemistry 37:16106-16115(1998).
RN   [11]
RP   STRUCTURE BY NMR OF 270-421.
RX   PubMed=11754837; DOI=10.1016/S0896-6273(01)00548-7;
RA   Fernandez I., Arac D., Ubach J., Gerber S.H., Shin O., Gao Y.,
RA   Anderson R.G., Suedhof T.C., Rizo J.;
RT   "Three-dimensional structure of the synaptotagmin 1 C2B-domain:
RT   synaptotagmin 1 as a phospholipid binding machine.";
RL   Neuron 32:1057-1069(2001).
RN   [12]
RP   MUTAGENESIS OF ILE-367.
RX   PubMed=25705886; DOI=10.1172/JCI79765;
RA   Baker K., Gordon S.L., Grozeva D., van Kogelenberg M., Roberts N.Y.,
RA   Pike M., Blair E., Hurles M.E., Chong W.K., Baldeweg T., Kurian M.A.,
RA   Boyd S.G., Cousin M.A., Raymond F.L.;
RT   "Identification of a human synaptotagmin-1 mutation that perturbs
RT   synaptic vesicle cycling.";
RL   J. Clin. Invest. 125:1670-1678(2015).
CC   -!- FUNCTION: May have a regulatory role in the membrane interactions
CC       during trafficking of synaptic vesicles at the active zone of the
CC       synapse. It binds acidic phospholipids with a specificity that
CC       requires the presence of both an acidic head group and a diacyl
CC       backbone. A Ca(2+)-dependent interaction between synaptotagmin and
CC       putative receptors for activated protein kinase C has also been
CC       reported. It can bind to at least three additional proteins in a
CC       Ca(2+)-independent manner; these are neurexins, syntaxin and AP2.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC       Note=Binds 3 Ca(2+) ions per subunit. The ions are bound to the C2
CC       domains.;
CC   -!- SUBUNIT: Homotetramer (Probable). Interacts with SCAMP5 and STON2.
CC       Forms a complex with SV2B, syntaxin 1 and SNAP25 (By similarity).
CC       Interacts with RIMS1. Interacts with SV2A, SV2B and SV2C.
CC       {ECO:0000250, ECO:0000269|PubMed:11438518,
CC       ECO:0000269|PubMed:15866046, ECO:0000269|PubMed:8910372,
CC       ECO:0000305}.
CC   -!- INTERACTION:
CC       Self; NbExp=4; IntAct=EBI-458098, EBI-458098;
CC       P18484:Ap2a2; NbExp=5; IntAct=EBI-458098, EBI-539360;
CC       Q02294:Cacna1b; NbExp=2; IntAct=EBI-458098, EBI-540038;
CC       Q00954:Scn1b; NbExp=2; IntAct=EBI-458098, EBI-2619363;
CC       P04775:Scn2a; NbExp=2; IntAct=EBI-458098, EBI-2619448;
CC       Q8WXE9:STON2 (xeno); NbExp=2; IntAct=EBI-458098, EBI-539742;
CC       Q02563:Sv2a; NbExp=2; IntAct=EBI-458098, EBI-466194;
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle,
CC       synaptic vesicle membrane; Single-pass membrane protein.
CC       Cytoplasmic vesicle, secretory vesicle, chromaffin granule
CC       membrane; Single-pass membrane protein. Cytoplasm. Note=Synaptic
CC       vesicles and chromaffin granules.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in rostral,
CC       phylogenetically younger brain regions, and in some endocrine
CC       tissues.
CC   -!- DOMAIN: The first C2 domain mediates Ca(2+)-dependent phospholipid
CC       binding. {ECO:0000269|PubMed:8910372}.
CC   -!- DOMAIN: The second C2 domain mediates interaction with SV2A and
CC       probably with STN2. {ECO:0000269|PubMed:8910372}.
CC   -!- SIMILARITY: Belongs to the synaptotagmin family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 2 C2 domains. {ECO:0000255|PROSITE-
CC       ProRule:PRU00041}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X52772; CAA36981.1; -; mRNA.
DR   EMBL; AJ617615; CAE85101.1; -; mRNA.
DR   EMBL; DQ181550; ABA00482.1; -; mRNA.
DR   PIR; S09595; S09595.
DR   RefSeq; NP_001028852.2; NM_001033680.2.
DR   UniGene; Rn.216272; -.
DR   PDB; 1BYN; NMR; -; A=140-267.
DR   PDB; 1K5W; NMR; -; A=270-421.
DR   PDB; 1RSY; X-ray; 1.90 A; A=132-266.
DR   PDB; 1TJM; X-ray; 1.18 A; A=271-421.
DR   PDB; 1TJX; X-ray; 1.04 A; A=271-421.
DR   PDB; 1UOV; X-ray; 1.65 A; A=271-421.
DR   PDB; 1UOW; X-ray; 1.04 A; A=271-421.
DR   PDB; 2YOA; X-ray; 1.50 A; A/B=271-421.
DR   PDB; 4WEE; X-ray; 0.89 A; A=140-266.
DR   PDBsum; 1BYN; -.
DR   PDBsum; 1K5W; -.
DR   PDBsum; 1RSY; -.
DR   PDBsum; 1TJM; -.
DR   PDBsum; 1TJX; -.
DR   PDBsum; 1UOV; -.
DR   PDBsum; 1UOW; -.
DR   PDBsum; 2YOA; -.
DR   PDBsum; 4WEE; -.
DR   ProteinModelPortal; P21707; -.
DR   SMR; P21707; 140-418.
DR   BioGrid; 247745; 1.
DR   DIP; DIP-29064N; -.
DR   IntAct; P21707; 16.
DR   MINT; MINT-4542559; -.
DR   STRING; 10116.ENSRNOP00000049624; -.
DR   PhosphoSite; P21707; -.
DR   PaxDb; P21707; -.
DR   PRIDE; P21707; -.
DR   Ensembl; ENSRNOT00000048880; ENSRNOP00000049624; ENSRNOG00000006426.
DR   Ensembl; ENSRNOT00000088950; ENSRNOP00000069194; ENSRNOG00000006426.
DR   GeneID; 25716; -.
DR   KEGG; rno:25716; -.
DR   UCSC; RGD:3803; rat.
DR   CTD; 6857; -.
DR   RGD; 3803; Syt1.
DR   eggNOG; COG5038; -.
DR   GeneTree; ENSGT00760000118973; -.
DR   HOGENOM; HOG000232127; -.
DR   HOVERGEN; HBG005010; -.
DR   InParanoid; P21707; -.
DR   KO; K15290; -.
DR   OMA; HDIIGEY; -.
DR   OrthoDB; EOG78PV8W; -.
DR   PhylomeDB; P21707; -.
DR   TreeFam; TF315600; -.
DR   Reactome; REACT_289838; GABA synthesis, release, reuptake and degradation.
DR   Reactome; REACT_319987; Glutamate Neurotransmitter Release Cycle.
DR   Reactome; REACT_340834; Norepinephrine Neurotransmitter Release Cycle.
DR   Reactome; REACT_352964; Acetylcholine Neurotransmitter Release Cycle.
DR   EvolutionaryTrace; P21707; -.
DR   NextBio; 607797; -.
DR   PRO; PR:P21707; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   ExpressionAtlas; P21707; baseline and differential.
DR   Genevisible; P21707; RN.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0042584; C:chromaffin granule membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0031045; C:dense core granule; IDA:RGD.
DR   GO; GO:0060076; C:excitatory synapse; IDA:BHF-UCL.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043229; C:intracellular organelle; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0030141; C:secretory granule; IDA:RGD.
DR   GO; GO:0008021; C:synaptic vesicle; IDA:BHF-UCL.
DR   GO; GO:0030672; C:synaptic vesicle membrane; TAS:RGD.
DR   GO; GO:0043195; C:terminal bouton; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005509; F:calcium ion binding; IDA:RGD.
DR   GO; GO:0005544; F:calcium-dependent phospholipid binding; IDA:BHF-UCL.
DR   GO; GO:0048306; F:calcium-dependent protein binding; IDA:RGD.
DR   GO; GO:0005516; F:calmodulin binding; IDA:RGD.
DR   GO; GO:0030276; F:clathrin binding; IDA:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:RGD.
DR   GO; GO:0001786; F:phosphatidylserine binding; IDA:RGD.
DR   GO; GO:0005543; F:phospholipid binding; IDA:RGD.
DR   GO; GO:0008022; F:protein C-terminus binding; IPI:RGD.
DR   GO; GO:0000149; F:SNARE binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0019905; F:syntaxin binding; IDA:BHF-UCL.
DR   GO; GO:0017075; F:syntaxin-1 binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0007420; P:brain development; IEP:RGD.
DR   GO; GO:0017156; P:calcium ion-dependent exocytosis; TAS:RGD.
DR   GO; GO:0048791; P:calcium ion-dependent exocytosis of neurotransmitter; IBA:GO_Central.
DR   GO; GO:0005513; P:detection of calcium ion; IDA:RGD.
DR   GO; GO:0098746; P:fast, calcium ion-dependent exocytosis of neurotransmitter; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0045956; P:positive regulation of calcium ion-dependent exocytosis; IDA:RGD.
DR   GO; GO:0050806; P:positive regulation of synaptic transmission; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0031340; P:positive regulation of vesicle fusion; IDA:RGD.
DR   GO; GO:0017158; P:regulation of calcium ion-dependent exocytosis; IMP:RGD.
DR   GO; GO:1903305; P:regulation of regulated secretory pathway; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0051966; P:regulation of synaptic transmission, glutamatergic; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0051592; P:response to calcium ion; IDA:RGD.
DR   GO; GO:0048488; P:synaptic vesicle endocytosis; IBA:GO_Central.
DR   GO; GO:0016079; P:synaptic vesicle exocytosis; TAS:RGD.
DR   GO; GO:0048278; P:vesicle docking; IDA:RGD.
DR   Gene3D; 2.60.40.150; -; 2.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR001565; Synaptotagmin.
DR   InterPro; IPR015428; Synaptotagmin1.
DR   PANTHER; PTHR10024:SF183; PTHR10024:SF183; 1.
DR   Pfam; PF00168; C2; 2.
DR   PRINTS; PR00360; C2DOMAIN.
DR   PRINTS; PR00399; SYNAPTOTAGMN.
DR   SMART; SM00239; C2; 2.
DR   SUPFAM; SSF49562; SSF49562; 2.
DR   PROSITE; PS50004; C2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Cell junction; Complete proteome; Cytoplasm;
KW   Cytoplasmic vesicle; Direct protein sequencing; Glycoprotein;
KW   Lipoprotein; Membrane; Metal-binding; Palmitate; Phosphoprotein;
KW   Reference proteome; Repeat; Synapse; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    421       Synaptotagmin-1.
FT                                /FTId=PRO_0000183940.
FT   TOPO_DOM      1     57       Vesicular. {ECO:0000255}.
FT   TRANSMEM     58     79       Helical. {ECO:0000255}.
FT   TOPO_DOM     80    421       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      143    244       C2 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   DOMAIN      274    377       C2 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   REGION      135    381       Phospholipid binding. {ECO:0000305}.
FT   COMPBIAS     80    119       Lys-rich.
FT   METAL       171    171       Calcium 2; via carbonyl oxygen.
FT   METAL       172    172       Calcium 1.
FT   METAL       172    172       Calcium 2.
FT   METAL       178    178       Calcium 1.
FT   METAL       230    230       Calcium 1.
FT   METAL       230    230       Calcium 2.
FT   METAL       231    231       Calcium 1; via carbonyl oxygen.
FT   METAL       232    232       Calcium 1.
FT   METAL       232    232       Calcium 2.
FT   METAL       232    232       Calcium 3.
FT   METAL       235    235       Calcium 3.
FT   METAL       236    236       Calcium 3; via carbonyl oxygen.
FT   METAL       238    238       Calcium 2.
FT   METAL       238    238       Calcium 3.
FT   MOD_RES     128    128       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P21579}.
FT   MOD_RES     229    229       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P46096}.
FT   LIPID        74     74       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:12782290}.
FT   LIPID        75     75       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:12782290}.
FT   LIPID        77     77       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:12782290}.
FT   LIPID        79     79       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:12782290}.
FT   LIPID        82     82       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:12782290}.
FT   CARBOHYD     24     24       N-linked (GlcNAc...).
FT   MUTAGEN     367    367       I->T: Slows synaptic vesicle fusion
FT                                kinetics and impairs the kinetics of
FT                                synaptic vesicle endocytosis.
FT                                {ECO:0000269|PubMed:25705886}.
FT   CONFLICT    188    188       D -> E (in Ref. 1; CAA36981).
FT                                {ECO:0000305}.
FT   CONFLICT    374    374       G -> D (in Ref. 1; CAA36981).
FT                                {ECO:0000305}.
FT   CONFLICT    393    393       M -> I (in Ref. 1; CAA36981).
FT                                {ECO:0000305}.
FT   STRAND      144    152       {ECO:0000244|PDB:4WEE}.
FT   TURN        153    156       {ECO:0000244|PDB:4WEE}.
FT   STRAND      157    166       {ECO:0000244|PDB:4WEE}.
FT   HELIX       172    174       {ECO:0000244|PDB:4WEE}.
FT   STRAND      179    187       {ECO:0000244|PDB:4WEE}.
FT   STRAND      205    212       {ECO:0000244|PDB:4WEE}.
FT   HELIX       216    219       {ECO:0000244|PDB:4WEE}.
FT   STRAND      223    230       {ECO:0000244|PDB:4WEE}.
FT   STRAND      233    235       {ECO:0000244|PDB:4WEE}.
FT   STRAND      238    246       {ECO:0000244|PDB:4WEE}.
FT   HELIX       247    249       {ECO:0000244|PDB:4WEE}.
FT   STRAND      256    261       {ECO:0000244|PDB:4WEE}.
FT   STRAND      275    283       {ECO:0000244|PDB:1TJX}.
FT   TURN        284    287       {ECO:0000244|PDB:1TJX}.
FT   STRAND      288    298       {ECO:0000244|PDB:1TJX}.
FT   STRAND      310    318       {ECO:0000244|PDB:1TJX}.
FT   STRAND      321    327       {ECO:0000244|PDB:1TJX}.
FT   STRAND      338    346       {ECO:0000244|PDB:1TJX}.
FT   HELIX       349    354       {ECO:0000244|PDB:1TJX}.
FT   STRAND      356    363       {ECO:0000244|PDB:1TJX}.
FT   STRAND      366    368       {ECO:0000244|PDB:1TJX}.
FT   STRAND      371    379       {ECO:0000244|PDB:1TJX}.
FT   HELIX       384    395       {ECO:0000244|PDB:1TJX}.
FT   STRAND      396    399       {ECO:0000244|PDB:1K5W}.
FT   STRAND      401    406       {ECO:0000244|PDB:1TJX}.
FT   HELIX       410    417       {ECO:0000244|PDB:1TJX}.
SQ   SEQUENCE   421 AA;  47399 MW;  06CE28F04C97A722 CRC64;
     MVSASHPEAL AAPVTTVATL VPHNATEPAS PGEGKEDAFS KLKQKFMNEL HKIPLPPWAL
     IAIAIVAVLL VVTCCFCVCK KCLFKKKNKK KGKEKGGKNA INMKDVKDLG KTMKDQALKD
     DDAETGLTDG EEKEEPKEEE KLGKLQYSLD YDFQNNQLLV GIIQAAELPA LDMGGTSDPY
     VKVFLLPDKK KKFETKVHRK TLNPVFNEQF TFKVPYSELG GKTLVMAVYD FDRFSKHDII
     GEFKVPMNTV DFGHVTEEWR DLQSAEKEEQ EKLGDICFSL RYVPTAGKLT VVILEAKNLK
     KMDVGGLSDP YVKIHLMQNG KRLKKKKTTI KKNTLNPYYN ESFSFEVPFE QIQKVQVVVT
     VLDYDKIGKN DAIGKVFVGY NSTGAELRHW SDMLANPRRP IAQWHTLQVE EEVDAMLAVK
     K
//
